2005Chinese Journal of Cancer ResearchRequires access

Expression and clinical significance of E2F-3 and Bcl-2 in hepatocellular carcinoma

Xin-hua Ju, Jiyang Zhang, Zhen-long Xia

Open publisher page 1 citations

Abstract

Objective: To investigate the expression of E2F and Bcl-2 and the clinicopathological significance in hepatocellular carcinoma. Methods: The expressions of E2F-3 and Bcl-2 in 74 patients with hepatic carcinoma, paracarcinoma and 15 patients with liver cirrhosis were detected by S-P immunohistochemical staining. Results: The expression of E2F in hepatic carcinoma was significantly higher than that in paracarcinoma or liver cirrhosis (P<0.005), the expression of Bcl-2 in hepatic carcinoma was significantly higher than that in paracarcinoma (P<0.005), in which Bcl-2 expression was lower than in liver cirrhosis(P<0.05). The expression of E2F-3 was related with histological grade, tumor size, and the expression of Bcl-2 was related with histological grade, tumor size and tumor number. There was correlation between the expression of E2F-3 and Bcl-2 in hepatic carcinoma. Conclusion: E2F-3 and Bcl-2 expression may play an important role in development, progression and cell apoptosis of tumor.

About this research paper

What this paper is about

Objective: To investigate the expression of E2F and Bcl-2 and the clinicopathological significance in hepatocellular carcinoma. Methods: The expressions of E2F-3 and Bcl-2 in 74 patients with hepatic carcinoma, paracarcinoma and 15 patients with liver cirrhosis were detected by S-P immunohistochemical staining. Results: The expression of E2F in hepatic carcinoma was significantly higher than that in paracarcinoma or liver cirrhosis (P<0.005), the expression of Bcl-2 in hepatic carcinoma was significantly higher than that in paracarcinoma (P<0.005), in which Bcl-2 expression was lower than in liver cirrhosis(P<0.05). The expression of E2F-3 was related with histological grade, tumor size, and the expression of Bcl-2 was related with histological grade, tumor size and tumor number. There was correlation between the expression of E2F-3 and Bcl-2 in hepatic carcinoma. Conclusion: E2F-3 and Bcl-2 expression may play an important role in development, progression and cell apoptosis of tumor.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate the expression of E2F and Bcl-2 and the clinicopathological significance in hepatocellular carcinoma. Methods: The expressions of E2F-3 and Bcl-2 in 74 patients with hepatic carcinoma, paracarcinoma and 15 patients with liver cirrhosis were detected by S-P immunohistochemical staining. Results: The expression of E2F in hepatic carcinoma was significantly higher than that in paracarcinoma or liver cirrhosis (P<0.005), the expression of Bcl-2 in hepatic carcinoma was significantly higher than that in paracarcinoma (P<0.005), in which Bcl-2 expression was lower than in liver cirrhosis(P<0.05). The expression of E2F-3 was related with histological grade, tumor size, and the expression of Bcl-2 was related with histological grade, tumor size and tumor number. There was correlation between the expression of E2F-3 and Bcl-2 in hepatic carcinoma. Conclusion: E2F-3 and Bcl-2 expression may play an important role in development, progression and cell apoptosis of tumor.

Key concepts: Hepatocellular carcinoma, Cirrhosis, Immunohistochemistry, E2F, Medicine, Pathology, Apoptosis, Clinical significance

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and clinical significance of E2F-3 and Bcl-2 in hepatocellular carcinoma — Research Paper | ScholarLens